Sickle cell raises COVID risk, but vaccination lags

Adults with sickle cell disease around half as likely to have gotten initial SARS-CoV-2 doses as people without sickle cell disease

1:18 PM

Author | Kara Gavin

covid cell blue yellow sketched graphic
Jacob Dwyer, Justine Ross, Michigan Medicine

Despite the fact that people with sickle cell disease have a much higher risk of serious illness or death if they develop COVID-19, a study shows they’re also much less likely than those without sickle cell disease to have gotten vaccinated against coronavirus. 

Completion of the initial COVID-19 vaccination series was nearly two times lower for adults with sickle cell disease as others their age, the analysis of data in Michigan shows. 

In in teens and children over 5, who overall have lower rates of COVID-19 vaccination, those with sickle cell disease were far less likely than other young people to have gotten their doses by summer 2022, the analysis shows.

SEE ALSO: Most Children with Sickle Cell Anemia Not Receiving Key Medication

A team from Michigan Medicine, the University of Michigan’s academic medical center, published the findings in JAMA Network Open together with colleagues from the Michigan Department of Health and Human Services and U-M School of Public Health. 

The team behind the study runs the Michigan Sickle Cell Data Collection Program, part of the national Sickle Cell Data Collection Program funded by the Centers for Disease Control and Prevention. 

This population is chronically underserved in healthcare and society, emphasizing the importance of increasing the accessibility and acceptability of these vaccines." Sarah Reeves, Ph.D.

To produce the findings, the team linked individual-level data from the statewide sickle cell data collection program and immunization registry. In all, they had records from 3,424 people over age 5 with sickle cell disease, and 9.4 million Michiganders over age 5. 

In all, 61% of the Michiganders without sickle cell disease, but only 33.5% of those with sickle cell disease, had gotten at least the primary dose or doses of Pfizer, Moderna or Johnson & Johnson COVID-19 vaccines by August 2022. 

The very highest-risk group, those over 65, had the highest vaccination rates, at 74% for those with sickle cell disease and 87% for the general population. 

However, there are only 110 people with sickle cell disease in this age group due to a combination of early mortality and less comprehensive data for this age group. 

In adults age 18 to 64, the difference between the two groups was about the same as the overall average. 

But in children and teens with sickle cell disease, who the researchers had previously shown have a higher rate of hospitalization and death if they developed COVID-19 compared to young people without sickle cell disease, vaccination rates were much lower. 

Only 17% of children age 5 to 11 with sickle cell disease, and 31% of their counterparts age 12 to 17, had gotten even a primary series of COVID-19 vaccine. 

That’s compared with 25% and 41% of the general Michigan population in these age groups. 

SEE ALSO: Most babies with sickle cell disease face double disadvantage

"It is essential to develop targeted interventions to increase COVID-19 vaccination among people with sickle cell disease," said MiSCDC principal investigator Sarah Reeves, Ph.D.

 "This population is chronically underserved in healthcare and society, emphasizing the importance of increasing the accessibility and acceptability of these vaccines."

The lead author of the study is Hannah Peng, M.P.H., a senior statistician on the MiSCDC team. Both she and Reeves are members of the Susan B. Meister Child Health Evaluation and Research (CHEAR) Center in the U-M Department of Pediatrics. Reeves and co-authors Kevin Dombkowski, Dr.P.H., of Pediatrics and Melissa Creary, Ph.D., of U-M SPH, are members of the U-M Institute for Healthcare Policy and Innovation. 

The study was funded by the Centers for Disease Control and Prevention

Paper cited: “COVID-19 Immunization Coverage Among People With Sickle Cell Disease,” JAMA Network Open. DOI: 10.1001/jamanetworkopen.2023.51618

Sign up for Health Lab newsletters today. Get medical tips from top experts and learn about new scientific discoveries every week by subscribing to Health Lab’s two newsletters, Health & Wellness and Research & Innovation.

Sign up for the Health Lab Podcast: Add us on SpotifyApple Podcasts or wherever you get you listen to your favorite shows.


More Articles About: Covid-19 COVID-19 Vaccine Sickle Cell Anemia Immunizations and Illnesses Vaccines and Immunizations Immunizations Health Care Delivery, Policy and Economics
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of health care news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories hands on paper writing with a pen
Health Lab
Racial and ethnic designation inaccuracies in children's medical records may impede equity efforts
A study from the Michigan Child Health Equity Collaborative, also known as Mi-CHEC, found substantial errors across the three health systems in racial and ethnic designations in their electronic medical records. 
kids on bus schedule covid cells popping up blue
Health Lab
Back to school viruses: what’s new with parvovirus B19, RSV, flu and COVID in kids
An expert shares more about back to school seasonal viruses, such as parvovirus B19, RSV, flu and COVID.
brain with white showing and rest teal and doctor with flashlight walking up neck that are stairs and shining flashlight
Health Lab
Same person. Different place. Twice the odds of a dementia diagnosis
Dementia risks vary by person and by population. But a new study shows diagnosis of the disease varies by region even after those differences are taken into account.
teal background of three people thinking three different things regarding money and health
Health Lab
As election approaches, national poll shows which health topics concern older adults most
Health care costs of different kinds, and financial scams, are top of mind for people age 50 and older going into the November election.
Four examples of caregiving
Health Lab
Caregiving: Poll reveals who’s providing care and who they’re caring for
Caregivers are more likely to be in their 50s and early 60s, female and believe the government should take the lead on the cost of caring for older adults.
green background with white drawing of doctor at patient beside having conversation
Health Lab
Have a seat, doctor: Study suggests eye level connection makes a difference in hospitals
When doctors sit at hospitalized patients’ bedsides, it can have a more positive impact than if they stand, a review of data suggests – but a new study seeks to find out for sure.